Pediatric MS. Female Health. Prodromic MS - can the risk of conversion be reduced? HSCT in MS - new perspectives.

You can find the full text to read on my blog: https://ms-perspektive.com/032-ectrims-2023-day-3

The third day at MS Milan 2023 offered again lots of interesting topics. This time I selected the following ones:

• Paediatric MS
• Female health
• Prodromic MS
• HSCT in MS

"},"minimize_box":"yes","minimized_on":"tablet","hierarchical_view":"yes","min_height":{"unit":"px","size":"","sizes":[]},"min_height_tablet":{"unit":"px","size":"","sizes":[]},"min_height_mobile":{"unit":"px","size":"","sizes":[]}}" data-widget_type="table-of-contents.default"> Table of Contents

• Scientific Session 15: Paediatric MS - updates on diagnosis, prognostic and treatment
• Scientific Session 20: Female health
• Hot Topic 8: Prodromic MS - can we reduce the risk of MS conversion and progression?
• Hot Topic 9: HSCT in MS - a long story with new perspectives

Remark: As for the summaries before, I took most of the data and statements directly from the speakers presentations without any rewording.

---

With that I'm at the end of my summary of MSMILAN 2023. I hope the selected topics were interesting for you. There is still lots of open questions and many fields where research needs to find solutions. But with each step of understanding the disease better it is more likely to find ways to avoid the onset, find better symptomatic therapies and hopefully ways to reduce disability burden. As mentioned before, I'll try to get some of the experts for detailed interviews.

See you soon and try to make the best out of your life, Nele

For more information and positive thoughts, subscribe to my newsletter for free.

Click here for an overview of all podcast episodes published so far.